AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Sitalembic M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitalembic M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and vision impairment, potentially lessening the risk of cardiovascular events. Combiflex DM 50mg/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control; lifestyle choices significantly impact management. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential risk, especially with concomitant use of insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Potential drug interactions exist; disclose all medications to ensure treatment safety. Alcohol should be avoided due to its potential to lower blood sugar. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitalembic M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sitalembic M 50mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Sitalembic M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Sitalembic M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitalembic M 50mg/500mg tablets with a meal.

How Sitalembic M 50mg/500mg Tablet works:

Sitalembic M, a 50mg/500mg tablet, unites sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitalembic M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitalembic M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your physician for guidance.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalembic M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitalembic M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. The medication is contraindicated in patients with severe renal dysfunction. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely refrain from using Sitalembic M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitalembic M 50mg/500mg Tablet :

Should you forget to take a Sitalembic M 50mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 50mg/500mg Tablet

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Sitalembic M 50mg/500mg Tablet

The Sitalembic M 50mg/500mg tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication helps regulate blood sugar when coupled with a healthy diet and exercise regimen. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitalembic M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Consequently, untreated deficiency may result in anemia and neurological issues, manifesting as tingling or numbness in extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Sitalembic M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Patients exhibiting hypersensitivity to any Sitalembic M 50mg/500mg Tablet constituent should not use this medication. Similarly, its administration is contraindicated in individuals with severely compromised renal or hepatic function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol while taking Sitalembic M 50mg/500mg tablets is unsafe and may heighten the risk of lactic acidosis.
Retain this medication in its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Sitalembic M 50mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates avoidance in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitalembic M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication helps regulate blood sugar levels when combined with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and enhances insulin sensitivity. Sitagliptin, by inhibiting DPP-4, stimulates increased insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18 years old.
Sitalembic M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis can occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 50mg/500mg Tablet ingredient or inactive component should not take this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Sitalembic M 50mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon side effect of metformin, prompting its avoidance in patients with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitalembic M and seek immediate medical attention.
Prolonged Sitalembic M 50mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Store the medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Sitalembic M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and improves insulin responsiveness. Sitagliptin blocks DPP-4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitalembic M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalembic M 50mg/500mg Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 50mg/500mg Tablet with alcohol is unsafe due to a heightened risk of lactic acidosis.
Indeed, taking Sitalembic M 50mg/500mg tablets carries a risk of lactic acidosis, a serious medical condition characterized by excessive lactic acid in the bloodstream. Also termed Metformin-associated lactic acidosis (MALA), this complication is uncommon with metformin use. Consequently, its use is contraindicated in individuals with pre-existing kidney problems, the elderly, and those who consume substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, queasiness, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Sitalembic M and seek immediate medical attention.
Prolonged Sitalembic M 50mg/500mg Tablet use can lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Store the medication in its original, tightly sealed container, following the storage guidelines provided on the packaging. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Sitalembic M 50mg/500mg T...
151
MRP 176
14% off